Researchers Demand American Psychiatric Association Retract Study That Fabricated Benefits Of Antidepressants, Covered Up Adverse Health Effects

Celexa

Source: NaturalNews.com
Julie Wilson
August 9, 2016

A large group of medical doctors, psychiatrists and researchers are demanding that the American Psychiatric Association retract a shady study that relied upon industry influence to determine the effectiveness of an antidepressant that’s widely prescribed among children and teens.

The study, published more than a decade ago in the American Journal of Psychiatry, touted the benefits of Celexa in younger populations suffering from depression.

However, a recent analysis of the research found “gross misrepresentations” about the safety and effectiveness of the drug, including the fact that Celexa worked no better than the placebo.

Study showing benefits of Celexa in children was written by the drug’s maker

The researchers say that the study reflected the “pervasive influence” of the marketing objectives of Forest Laboratories, the Celexa manufacturer, adding that the “scientific” manuscript was “written primarily for marketing purposes and only secondarily as a peer-reviewed journal.”

In other words, the study was totally fabricated to extend the consumer base for Celexa to children and teens, the fastest growing demographic for which antidepressants are prescribed.

The analysis revealed that the study was written by none other than ghost writers employed by Forest Laboratories who “seriously misrepresented” the data about the drug’s safety and efficacy.

“Forest’s own internal documents disclosed in litigation show that company staff were aware that there were serious problems with the conduct of this trial but concealed the problems in advancing their commercial objectives,” said the researchers.

As reported by Stat News, “Procedural deviations in the study were not reported; negative outcomes were not reported; [and] side effects were misleadingly analyzed.”

Fabricated study continues to be cited by the pharmaceutical industry

The researchers’ letter demanding a retraction is dated August 1, 2016, and addressed to Dr. Maria Oquendo, president of the American Psychiatric Association. It asks Oquendo to urge the current editor of the American Journal of Psychiatry to issue a retraction.

“Our main concern is that children and adolescents are continuing to be at risk of harm unnecessarily because well-intentioned physicians have been misled,” they wrote.

“We believe that the unretracted … article represents a stain on the high standard of the American Journal of Psychiatry (AJP) and the American Psychiatric Association (APA). Neither the AJP nor the APA can claim to be a leader in scientific research.”

New research finds antidepressants totally ineffective and dangerous for children

The revelations come roughly two months after a groundbreaking report revealed that most antidepressants marketed for children and teens are not only ineffective, but downright dangerous.

The research, published in The Lancet, reports that out of 14 antidepressants, only one (Prozac) provided depression relief for children and teens. Other antidepressants such as Effexor increased the risk of suicidal thoughts and suicide attempts in younger populations.

The study is the most comprehensive analysis ever conducted regarding antidepressant use among children and teens.

Supermodel says antidepressants made her a ‘sociopath’

The adverse effects of antidepressants continue to be disclosed by both physicians and patients alike. English fashion model Cara Delevingne recently told Britain’s Esquire magazine that antidepressants turned her into a “sociopath.”

Delevingne, who took the drugs for two years as a teenager, said she lost all feelings, and was “just numb” until she stopped taking them.

“I didn’t feel s**t. It was horrible. I was like a sociopath. When something was funny I would go, ‘Ha ha!’ just because other people laughed, but then I’d stop immediately because I wasn’t really very good at faking it.”

Read More At: NaturalNews.com
_______________________________________________________________

Sources:

FreePDFHosting.com[PDF]

StatNews.com

CBSNews.com

CaraDelevingne.Esquire.co.uk

Science.NaturalNews.com

Bombshell Study Admits Antidepressants Increase Suicide Attempts In Teens & Are Completely Worthless For Treating Depression

Antidepressants
Source: NaturalNews.com
Julie Wilson
June 13, 2016

A bombshell study published in the medical journal The Lancet admits what Natural News and others in the holistic health community have been reporting for years: antidepressants kill. On Wednesday, researchers published the most comprehensive analysis to date of the safety and efficacy of widely prescribed antidepressants in children and teens.

What they found is that the majority of antidepressants prescribed to young people have far more risks than benefits, doing essentially nothing to ease symptoms of depression, while significantly increasing suicidal thoughts and suicide attempts, CBS News is reporting.

Out of 14 antidepressants analyzed by researchers, only one – fluoxetine (marketed under the name Prozac and Sarafem) – proved effective for relieving symptoms of depression better than a placebo pill. Venlafaxine (Effexor), on the other hand, was shown to increase the risk of suicidal tendencies in children and teens compared to a placebo and five other antidepressants.

The study results are major considering the fact that antidepressant use among young people is at an all-time high. Shockingly, children under 5-years-old are the fastest growing group being prescribed mind-altering drugs.

Most antidepressants do NOTHING to help depression, study finds

Antidepressant use among children and teens rose from 1.3 to 1.6 percent between 2005 and 2012, according to a separate study published in The Lancet.

As the authors of this latest study confirm, the implications of drugging children with powerful, mind-altering drugs is completely unpredictable, which is why international guidelines encourage doctors to use non-drug approaches including “cognitive behavioral or interpersonal therapy.”

Lead study author Dr. Andrea Cipriani says that because brains in children and teens are not yet developed, it’s important to lead with caution when prescribing medication, “because we don’t know the potential implications in the long term … .”

The U.S National Institutes of Health estimates that some 2.8 million children (or about 11 percent) between the ages of 12 and 17 have suffered from at least one episode of depression, for which we now know that antidepressant drugs are totally worthless.

Dr. Cipriani explains that depression in children differs widely from that of adults. “Not only is it still under-diagnosed and under-treated but also it tends to present in a different way,” he said. “Depressive symptoms in children and adolescents are rather undifferentiated. You notice more irritability, aggressive behavior and problems at school. And consequences of depressive episodes in children and adolescents are dramatic because they include impairments in their social functioning but also an increased risk of suicidal ideation and attempts.”

FDA privy to antidepressant harm in children for decades

The U.S. Food and Drug Administration has known for more than a decade that antidepressants pose immense harm to patients, particularly children, which is why it implemented “black box” warnings in 2004 for users under the age of 24. The labels clearly state that the drugs up your chances of becoming suicidal or intensify preexisting suicidal thoughts and behavior.

Yet, irresponsible physicians continue to push harmful drugs on children and teens that alter brain chemistry. Not only that, but doctors are increasingly prescribing the drugs for off-label uses.

This was substantiated just weeks ago in a study published in the May issue of the Journal of the American Medical Association (JAMA), which found that nearly half of people prescribed antidepressants aren’t even depressed.

After analyzing a decade of antidepressant prescription records, researchers concluded that only 55 percent were given for depression, while the remaining 45 percent was written for conditions such as anxiety, sleeping problems, pain, panic disorders and attention deficit hyperactivity disorder (ADHD).

Doctors prescribing depression pills for pretty much anything

Other off-label uses include digestive problems, eating disorders, migraines and menopausal symptoms. Twenty-nine percent of antidepressant prescriptions were written for off-label uses. The study authors expressed grave concerns about the fact that these drugs, which are proven to be dangerous, are being prescribed for conditions for which there is no evidence supporting their efficacy, or safety for that matter.

The reason doctors are pushing unproven drugs, is because they’re being advised to do so by Big Pharma, and not by scientific research, said the study authors.

Further illustrating just how worthless these drugs are, medical researcher Peter Gotzsche said last year that nearly all psychiatric drugs, including antidepressants, could be withdrawn from the market without damaging public health. In fact, he recommends it.

Read More At: NaturalNews.com